Published On: 8/24/2022
Durham-Based Target RWE Grows Data Abstraction, Curation Capabilities with Latest Acquisition
DURHAM, N.C., Aug. 24, 2022 /PRNewswire/ -- Real-world evidence leader Target RWE announced its latest acquisition of the curation team (legacy Real World Data team) from Ciox Health which will expand the company's real world data (RWD) solutions and capabilities. Effective today, this division will become part of Target RWE.
Over the past two years, Target RWE has been strategically investing in its real-world evidence (RWE) solutions, most notably with the purchase of analytics company NoviSci, Inc. in 2021. This will be the second acquisition completed by the company. The acquisition complements Target RWE's data abstraction and curation capabilities, especially on the retrieval and linking of real world datasets, which will help position the company as a market leader in the RWE field.
"Today's agreement not only propels Target RWE's data abstraction and curation capabilities, but it also signifies our dedication to generate the best real world data and evidence possible," said Derek Evans, CEO of Target RWE. "We are excited to work with the great team coming over from Ciox, who will add further efficiencies in clinical data abstraction and curation to our organization. We look forward to bringing our expertise to exciting projects and new customers as a result of this new partnership."
The acquisition will add roughly 35 full-time and part-time employees to Target RWE, increasing the company's overall headcount to approximately 150 nationwide. The company recently announced the launch of its new brand and Syndicated Science™ solution that will be unveiled at the International Conference on Pharmacoepidemiology (ICPE) 2022 in Copenhagen.
About Target RWE
As the industry's best-in-class, complete real world evidence (RWE) solution, Target RWE is a distinctly collaborative enterprise that unifies real world data (RWD) sets and advanced RWE analytics in an integrated community, shifting the paradigm in healthcare for how decisions are made to improve lives.
Target RWE sources unique, connected data sets across multiple therapeutic areas representing granular data from diverse patients in academic and community settings. Our rigorous, interactive, and advanced RWE analytics extract deep insights from RWD to answer important questions in healthcare. Target RWE brings together the brightest minds in healthcare through an unmatched community of key opinion leaders, patients, and healthcare stakeholders in a collaborative and dynamic model. www.targetrwe.com
Contact:
Kayla Slake
Marketing Manager
984.234.0268 ext 205
More News
-
03/08/2023
Ewa Kleczyk, PhD Featured on CIO Views Cover for March – A Memento to Women’s History Month & International Women’s Day -
02/28/2023
Longest Running Real World Dermatology Registry, TARGET-DERM, Offers Deep Insight into Complex Diseases -
01/11/2023
Target RWE Launches 35 New Disease State Registries in Complex Indications with High Unmet Medical Needs and Rapidly Evolving Therapies -
11/04/2022
New TARGET-NASH Real World Data Show Non-Alcoholic Fatty Liver Disease Severity and Gender Linked to Disparities in Polypharmacy -
10/18/2022
Target RWE and the American Association for the Study of Liver Diseases Announce Research Agreement for Cirrhosis Quality Collaborative